VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, announced that… Read More
The Road to Recovery Initiative (R2R) is an innovative model of care that aims to transform the way substance use treatment is coordinated and delivered in BC. Co-developed by the… Read More
In vitro Alzheimer’s disease studies show that INM-901 treated groups display neuroprotection and extended neurite length, a potential marker for improved neuronal function INM-901 treated groups in an in vivo… Read More
Researchers funded by The Terry Fox Research Institute have demonstrated that by analyzing patients’ blood samples, they are able to detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited… Read More
VANCOUVER, BC — SnapCyte Solutions Inc. has received a Mitacs Accelerate Grant for the project ‘Developing cutting-edge AI-powered tools to perform cell analytics in life science research laboratories’. The project will… Read More
